X
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN SUSP ISOPHANE RECOMBINANT HUMAN, with a corresponding application number 19959 and regulatory information .
proudly manufactured in the
Novo Nordisk's NOVOLIN N INJECTABLE;INJECTION, medication with 100 UNITS/ML of INSULIN SUSP ISOPHANE RECOMBINANT HUMAN.